Clinical Trials Logo

Clinical Trial Summary

Several technological challenges exist to apply Magnetic Resonance guided High Intensity Focused Ultrasound (MRgHIFU) for treatment of liver or kidney in particular challenges related to the motion of these organs. This study tests a new software to improve thermometry accuracy in mobile organs in patients with liver or kidney tumors. In the same time, the trajectory of the target in 3D is analyzed.


Clinical Trial Description

Liver and kidney tumors represent a major health problem because most patients are unsuitable for curative treatment with surgery. Thus, percutaneous ablation, using radio frequency (RF), is preferred : an interstitial electrode that delivers alternative current is placed into the tissue. Consequently, the development of an accurate and completely non-invasive method based on MR guided HIFU treatment is of particular interest since the energy source is located outside the body. There is no incision. For the patient, it provides a treatment option with reduced trauma and improved quality of life, and for the society, it provides reduced hospitalization time and reduced costs.

MRgHIFU has already been tested clinically in tumors of immobilized tissues as uterine leiomyoma. However, several technological challenges exist to apply it for treatment of the liver or the kidney especially challenges related to the motions of these organs. In order to improve the therapeutic efficiency and the safety of the intervention, real time mapping of temperature and thermal dose appear to offer the best strategy to optimize such interventions and provide clinical therapy endpoints. Among imaging modalities, MRI Proton Resonance Frequency based method appears to be the ideal tool for temperature mapping.

One major drawback of PRF thermometry is its high sensitivity to motion. Therefore motion correction is necessary to use PRF thermometry in mobile organs such as the liver or kidneys. To correct artefacts generated in temperature maps by periodical organ motion, a new technique was developed in the IMF lab of Bordeaux University Hospital.

The primary outcome of this study is to evaluate the precision of multiplanar MR imaging with real time motion compensation in hepatic or renal tumour patient.

Secondary outcomes are :

- Characterization of 3d movements of the tumour and test if imaging is improved when the imaging plan contains the main axis of movement.

- Ballistic: we need to identify all anatomical structures which are in the way of the HIFU beam in order to define the types of tumour suitable for future treatments

- Another outcome is to define what modifications are needed in order to treat patients such as depth of treatment, power level. We also need to see the target, ribs, and the transducer in order to evaluate the number of transducer elements to be turned off during treatment. ;


Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01197820
Study type Interventional
Source University Hospital, Bordeaux
Contact
Status Terminated
Phase N/A
Start date September 2010
Completion date May 2011

See also
  Status Clinical Trial Phase
Terminated NCT00942383 - Freehand Ultrasound Elasticity Imaging in Liver Surgery
Completed NCT01782573 - The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients Phase 4
Active, not recruiting NCT03432806 - A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Completed NCT01403727 - Electromagnetic Tracking of Devices During Biopsy Procedures N/A
Recruiting NCT00691691 - Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors Phase 2
Terminated NCT00955097 - Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors Phase 1
Recruiting NCT02184182 - Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS) Phase 2
Completed NCT02162732 - Molecular-Guided Therapy for Childhood Cancer N/A
Recruiting NCT05990257 - CMRA for US-guided-MWA of Liver Tumors N/A
Completed NCT00828607 - Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver Masses N/A
Completed NCT00960609 - Communicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound Study N/A
Completed NCT05445973 - Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation N/A
Completed NCT03171428 - Hepatectomy With or Without the Thoraco-abdominal Approach N/A
Completed NCT02509507 - Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 Phase 1/Phase 2
Completed NCT00877136 - A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Terminated NCT04315883 - Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
Completed NCT01031784 - Radioactive Holmium Microspheres for the Treatment of Liver Metastases Phase 1
Active, not recruiting NCT00845689 - Prevention of Liver Damage During Liver Surgery Phase 1/Phase 2